JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, cilt.87, sa.9, ss.1005-1015, 2016 (SCI-Expanded, Scopus)
Objective Antibodies to cell surface central nervous system proteins help to diagnose conditions which often respond to immunotherapies. The assessment of antibody assays needs to reflect their clinical utility. We report the results of a multicentre study of aquaporin (AQP) 4 antibody (AQP4-Ab) assays in neuromyelitis optica spectrum disorders (NMOSD).